Cross-Border Impact Ventures (CBIV) has raised over $90 million in investor commitments to close its Women’s and Children’s Health Technology Fund. CBIV is a venture capital firm that focuses on investing in technology companies that address the health needs of women, children, and adolescents or make health systems more resilient. The firm’s investments include medical device, diagnostic, and digital health companies based in North America and Europe that are globally relevant, including in emerging markets. The fund uses a gender lens to invest and works with portfolio companies to improve diversity and expand their reach.
The fund has attracted a range of investors, including the German state-owned financial institution KfW, UK-based M&G’s Catalyst, and a fund of funds managed by Wire Group. Other investors include family offices such as Ellevest and the Skoll Foundation, foundations such as the Fondation du Grand Montréal, and previous investors like the Children’s Investment Fund Foundation and the Johnson & Johnson Foundation. The fund also benefits from a guarantee provided by the Swedish International Development Cooperation Agency (SIDA).
Since its launch in December 2021, CBIV has made five investments in health technology companies. These investments include Pendulum, a health infrastructure software company; Daye, a gynecological care-as-a-service platform; mOm Incubators, a medical device company that has created a portable incubator for neonatal care; Sonio, an AI-enabled software company for fetal ultrasound practitioners; and OncoLens, a digital health platform company providing care management solutions for cancer patients and healthcare providers.
Annie Thériault, Managing Partner at CBIV, said, “Our current portfolio has the potential to make a difference in the lives of millions of women, children, and adolescents in North America and Europe, in addition to targeting underserved populations in emerging markets.”
Donna Parr, Managing Partner at CBIV, added, “We are building a portfolio of investments that we know is of interest to strategic acquirers.”
Cross-Border Impact Ventures is focused on revolutionizing venture investing in health technology with a mission to expand access to world-class technologies globally.
